These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33582321)

  • 1. Effect of bile acids on the expression of MRP3 and MRP4: An In vitro study in HepG2 cell line.
    Pérez-Pineda SI; Baylón-Pacheco L; Espíritu-Gordillo P; Tsutsumi V; Rosales-Encina JL
    Ann Hepatol; 2021; 24():100325. PubMed ID: 33582321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy.
    Miura T; Kimura N; Yamada T; Shimizu T; Nanashima N; Yamana D; Hakamada K; Tsuchida S
    J Hepatol; 2011 Aug; 55(2):407-14. PubMed ID: 21167233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
    Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.
    Chai J; He Y; Cai SY; Jiang Z; Wang H; Li Q; Chen L; Peng Z; He X; Wu X; Xiao T; Wang R; Boyer JL; Chen W
    Hepatology; 2012 May; 55(5):1485-94. PubMed ID: 22105759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter.
    Inokuchi A; Hinoshita E; Iwamoto Y; Kohno K; Kuwano M; Uchiumi T
    J Biol Chem; 2001 Dec; 276(50):46822-9. PubMed ID: 11590139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
    Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
    J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.
    Denk GU; Soroka CJ; Takeyama Y; Chen WS; Schuetz JD; Boyer JL
    J Hepatol; 2004 Apr; 40(4):585-91. PubMed ID: 15030973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFα Induces Multidrug Resistance-Associated Protein 4 Expression through p38-E2F1-Nrf2 Signaling in Obstructive Cholestasis.
    Lian W; Liu X; Chen W
    Yonsei Med J; 2019 Nov; 60(11):1045-1053. PubMed ID: 31637886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.
    Ruiz ML; Rigalli JP; Arias A; Villanueva S; Banchio C; Vore M; Mottino AD; Catania VA
    Drug Metab Dispos; 2013 Feb; 41(2):275-80. PubMed ID: 23077105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Function of Multidrug Resistance-associated Protein 3 in the Transport of Bile Acids under Normal Physiological and Lithocholic Acid-induced Cholestasis Conditions.
    Wang W; Zeng S; Hu M; Liu Z; Gong L
    Curr Drug Metab; 2021; 22(5):353-362. PubMed ID: 33461458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
    PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
    Beilke LD; Besselsen DG; Cheng Q; Kulkarni S; Slitt AL; Cherrington NJ
    Toxicol Sci; 2008 Mar; 102(1):196-204. PubMed ID: 18032408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
    Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
    Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.
    Renga B; Migliorati M; Mencarelli A; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
    Biochim Biophys Acta; 2011 Mar; 1809(3):157-65. PubMed ID: 21296199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice.
    Assem M; Schuetz EG; Leggas M; Sun D; Yasuda K; Reid G; Zelcer N; Adachi M; Strom S; Evans RM; Moore DD; Borst P; Schuetz JD
    J Biol Chem; 2004 May; 279(21):22250-7. PubMed ID: 15004017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
    Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
    Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis.
    Chai J; Luo D; Wu X; Wang H; He Y; Li Q; Zhang Y; Chen L; Peng ZH; Xiao T; Wang R; Chen W
    J Gastrointest Surg; 2011 Jun; 15(6):996-1004. PubMed ID: 21359593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.